These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 17936446
1. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Hibbert CL, Piedra PA, McLaurin KK, Vesikari T, Mauskopf J, Mahadevia PJ. Vaccine; 2007 Nov 19; 25(47):8010-20. PubMed ID: 17936446 [Abstract] [Full Text] [Related]
6. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Pediatrics; 2007 Sep 19; 120(3):e553-64. PubMed ID: 17698577 [Abstract] [Full Text] [Related]
7. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group. Pediatr Infect Dis J; 2006 Oct 19; 25(10):860-9. PubMed ID: 17006278 [Abstract] [Full Text] [Related]
8. Universal influenza vaccination and live attenuated influenza vaccination of children. Glezen WP. Pediatr Infect Dis J; 2008 Oct 19; 27(10 Suppl):S104-9. PubMed ID: 18820568 [Abstract] [Full Text] [Related]
9. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD, D153-P504 LAIV Study Group. Pediatr Infect Dis J; 2009 May 19; 28(5):365-71. PubMed ID: 19395948 [Abstract] [Full Text] [Related]
10. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses. Nichol KL, Mendelman P. Virus Res; 2004 Jul 19; 103(1-2):3-8. PubMed ID: 15163481 [Abstract] [Full Text] [Related]
11. Cost-effectiveness of influenza vaccination of healthy children. Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Vaccine; 2006 Jun 05; 24(23):4934-41. PubMed ID: 16678945 [Abstract] [Full Text] [Related]
12. Influenza vaccine 2008-2009. Med Lett Drugs Ther; 2008 Oct 06; 50(1296):77-9. PubMed ID: 18833032 [Abstract] [Full Text] [Related]
13. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine. Vesikari T, Karvonen A, Korhonen T, Edelman K, Vainionpää R, Salmi A, Saville MK, Cho I, Razmpour A, Rappaport R, O'Neill R, Georgiu A, Gruber W, Mendelman PM, Forrest B, CAIV-T Transmission Study Group. Pediatr Infect Dis J; 2006 Jul 06; 25(7):590-5. PubMed ID: 16804427 [Abstract] [Full Text] [Related]
14. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial. Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC. J Med Virol; 2009 May 06; 81(5):908-14. PubMed ID: 19319953 [Abstract] [Full Text] [Related]
15. Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010. Committee on Infectious Diseases. Pediatrics; 2009 Oct 06; 124(4):1216-26. PubMed ID: 19736264 [Abstract] [Full Text] [Related]
16. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W. Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661 [Abstract] [Full Text] [Related]
17. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine. Myers CA, Faix DJ, Blair PJ. Clin Infect Dis; 2011 Jul 15; 53(2):207-8. PubMed ID: 21690631 [No Abstract] [Full Text] [Related]
18. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]